CONSUN PHARMA (01681): Lee Cheuk Kwong appointed as Independent Non-executive Director.
Kangzin Pharmaceutical (01681) announced that, effective from February 24, 2025, Ms. Chen Yujun has resigned as an independent...
CONSUN PHARMA (01681) announced that, effective from February 24, 2025: Ms. Chen Yujun has resigned as an independent non-executive director and will no longer serve as chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Li Zhuoguang has been appointed as an independent non-executive director, chairperson of the audit committee, and as a member of the nomination committee, remuneration committee, and ESG committee; Mr. Fang Peicheng will no longer concurrently serve as the Chief Financial Officer; Ms. Chen Yujun has been appointed as the Chief Financial Officer.
Related Articles

Intel Corporation relies on outsourcing revenue to support its business, while Wells Fargo & Company sees potential in AMD seizing market share.

HK Bull/Bear Outstanding Qty Ratio(71:29) | January 24th

US Stock Market Move | EquipmentShare.com(EQPT.US) Debuts on the US Stock Market with a First-Day Trading Increase of 32.9%
Intel Corporation relies on outsourcing revenue to support its business, while Wells Fargo & Company sees potential in AMD seizing market share.

HK Bull/Bear Outstanding Qty Ratio(71:29) | January 24th

US Stock Market Move | EquipmentShare.com(EQPT.US) Debuts on the US Stock Market with a First-Day Trading Increase of 32.9%

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


